跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stalev - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stalev
Approved
STANDARD
Stalev
Orion Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b333ef5eb50b58db
Company
Orion Corporation
Type
Standard
Approval Details
Approval Id
b333ef5eb50b58db
Drug Approval Philippines Name
Stalev
Product Name
Stalev
Registration Number
DRP-8090
Brand Name
Stalev
Generic Name
Levodopa + Carbidopa + Entecapone
Dosage Form
Film-Coated Tablet
Dosage Strength
50mg/12.5mg/200mg
Manufacturer
Orion Corporation
Trader
Alvogen Emerging Markets Holdings Limited
Importer
DKSH Philippines, Inc.
Company Detail Path
/organization/orion-corporation
Issuance Date
25 May 2025
Expiry Date
21 June 2031
Pharmacologic Category
Anti-parkinsonism
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b333ef5eb50b58db
Type
Standard
Back to Philippines FDA Approvals